PMS27 A COST-EFFECTIVENESS ANALYSIS FROM AN INSTITUTIONAL PERSPECTIVE TO COMPARE ZOLEDRONIC ACID WITH STANDARD OF CARE IN THE PREVENTION OF HIP FRACTURES IN PATIENTS WITH OSTEOPOROSIS

May 1, 2011, 00:00
10.1016/j.jval.2011.02.712
https://www.valueinhealthjournal.com/article/S1098-3015(11)00851-5/fulltext
Title : PMS27 A COST-EFFECTIVENESS ANALYSIS FROM AN INSTITUTIONAL PERSPECTIVE TO COMPARE ZOLEDRONIC ACID WITH STANDARD OF CARE IN THE PREVENTION OF HIP FRACTURES IN PATIENTS WITH OSTEOPOROSIS
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)00851-5&doi=10.1016/j.jval.2011.02.712
First page : A128
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 174
Categories :
Tags :
Regions :
ViH Article Tags :